<code id='295B06CFE9'></code><style id='295B06CFE9'></style>
    • <acronym id='295B06CFE9'></acronym>
      <center id='295B06CFE9'><center id='295B06CFE9'><tfoot id='295B06CFE9'></tfoot></center><abbr id='295B06CFE9'><dir id='295B06CFE9'><tfoot id='295B06CFE9'></tfoot><noframes id='295B06CFE9'>

    • <optgroup id='295B06CFE9'><strike id='295B06CFE9'><sup id='295B06CFE9'></sup></strike><code id='295B06CFE9'></code></optgroup>
        1. <b id='295B06CFE9'><label id='295B06CFE9'><select id='295B06CFE9'><dt id='295B06CFE9'><span id='295B06CFE9'></span></dt></select></label></b><u id='295B06CFE9'></u>
          <i id='295B06CFE9'><strike id='295B06CFE9'><tt id='295B06CFE9'><pre id='295B06CFE9'></pre></tt></strike></i>

          focus

          focus

          author:entertainment    Page View:42176
          The FDA building -- First Opinion coverage from STAT
          Adobe

          The Food and Drug Administration on Thursday approved the first medicine developed specifically to treat the serious liver disease known as MASH.

          The pill, called Rezdiffra, is made by Madrigal Pharmaceuticals.

          advertisement

          Metabolic dysfunction-associated steatohepatitis, or MASH, is often associated with obesity. The accumulation of fat in the liver causes inflammation, which leads to fibrosis, or liver scarring, and can progress in more advanced stages to cirrhosis, cancer, and the need for a liver transplant.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news
          Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

          SteffenTrumpf/picturealliance/GettyImagesWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? 

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          First recipient of genetically engineered pig kidney has died

          RickSlayman,holdinghandswithhispartner,Faren,poseswithmembersofhisMassachusettsGeneralHospitalmedica